Get the latest tech news
Digital twins of human organs are here. They’re set to transform medical treatment.
The models can be used to plan surgeries and in the future could be used to help trial new drugs.
Just as sensors can deliver data from a person’s heart, the computer can model potential outcomes to make predictions and feed them back to a patient or health-care provider. Now he is hoping to use those synthetic eyes in drug trials—among other things, to find the best treatment doses for people with age-related macular degeneration, a common condition that can lead to blindness. Jantina de Vries, an ethicist at the University of Cape Town, points out that the data used to create digital twins and synthetic “quasi patients” will come from people who can be scanned, measured, and monitored.
Or read this on r/technology
